Share
Other content recommended for you
- Cognitive neuroenhancement: false assumptions in the ethical debate
- Neuroenhancers, addiction and research ethics
- Sugar addiction: is it real? A narrative review
- Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology
- Neuropsychiatry of the basal ganglia
- Extrastriatal dopaminergic changes in Parkinson’s disease patients with impulse control disorders
- Neuroenhancing public health
- Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management
- The billion dollar business of being smart
- GL.01 Dopamine in health and disease